ArticleBiomedicines2023
Towards Artificial Intelligence Applications in Next Generation Cytopathology.
Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence in cytopathological applications for cancer: a review of accuracy and analytic validity.European journal of medical research · 2024Pooled it
- The Augmented Cytopathologist: A Conceptual Exploratory Narrative Review on Immersive and Vision-Language Models Tools in Digital Pathology.Journal of imaging · 2026Review
- Estimating Tumor Proportion in Smear Slides for Reliable Molecular Analysis.Turk patoloji dergisi · 2026Article
- Impact of Magnification, Image Type, and Number on Convolutional Neural Network Performance in Differentiating Canine Large Cell Lymphoma From Non-Lymphoma via Lymph Node Cytology.Veterinary clinical pathology · 2025Article
- Surveying the Digital Cytology Workflow in Italy: An Initial Report on AI Integration Across Key Professional Roles.Healthcare (Basel, Switzerland) · 2025Article
- Revolutionizing Cytology and Cytopathology with Natural Language Processing and Chatbot Technologies: A Narrative Review on Current Trends and Future Directions.Bioengineering (Basel, Switzerland) · 2024Review
- Metaverse and its impact on medical education and health care system: A narrative review.Health science reports · 2024Article
- AI-assisted rapid on-site evaluation ROSE of EUS-FNA cytopathology for pancreatic solid lesions: A two-stage deep learning approach.Endoscopic ultrasoundArticle
- Interobserver Reliability of Milan and Modified Milan System for Reporting Salivary Gland Cytopathology: An Institutional Experience.Journal of cytologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Over the last 20 years we have seen an increase in techniques in the field of computational pathology and machine learning, improving our ability to analyze and interpret imaging. Neural networks, in particular, have been used for more than thirty years, starting with the computer assisted smear test using early generation models. Today, advanced machine learning, working on large image data sets, has been shown to perform classification, detection, and segmentation with remarkable accuracy and generalization in several domains. Deep learning algorithms, as a branch of machine learning, are thus attracting attention in digital pathology and cytopathology, providing feasible solutions for accurate and efficient cytological diagnoses, ranging from efficient cell counts to automatic classification of anomalous cells and queries over large clinical databases. The integration of machine learning with related next-generation technologies powered by AI, such as augmented/virtual reality, metaverse, and computational linguistic models are a focus of interest in health care digitalization, to support education, diagnosis, and therapy. In this work we will consider how all these innovations can help cytopathology to go beyond the microscope and to undergo a hyper-digitalized transformation. We also discuss specific challenges to their applications in the field, notably, the requirement for large-scale cytopathology datasets, the necessity of new protocols for sharing information, and the need for further technological training for pathologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.